Position in AKBA
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$17,442
-$3,408 QoQ
Shares Held
15,300
+2.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#120
of 169 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Onyx Bridge Wealth Group LLC holds $325,045 across 4 Drug Manufacturers - Specialty & Generic names. AKBA ranks #3 (5.4% of the industry book) .
All Filings in AKBA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,442 | 15,300 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $20,850 | 15,000 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $24,150 | 15,000 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $40,950 | 15,000 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $54,600 | 15,000 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $28,800 | 15,000 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $28,500 | 15,000 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $19,800 | 15,000 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $15,300 | 15,000 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $27,450 | 15,000 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $15,500 | 12,500 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $14,250 | 12,500 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $11,437 | 12,500 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $7,000 | 12,500 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $7,212 | 12,500 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $3,950 | 12,500 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $4,412 | 12,500 | Shares | Sole | 2022-07-25 | |
| No filing history on record for this holder in this stock. | ||||||